<DOC>
<DOCNO>EP-0655456</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PHOSPHONIC DIESTER DERIVATIVE
</INVENTION-TITLE>
<CLASSIFICATIONS>C07F96558	C07F900	C07F96512	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07F	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07F9	C07F9	C07F9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
A phosphonic diester derivative represented by general formula (1) and useful as remedies for hyperlipidemia, 
hypertension, diabetes, and so forth. In said formula, A represents oxygen or sulfur; R¹, R², R⁹ and R¹⁰ represent each 

independently hydrogen, lower alkoxy, nitro, lower alkyl, halogenated lower alkyl or halogen; R³ represents phenyl, 
-B-R⁶ (wherein B represents oxygen or sulfur; and R⁶ represents hydrogen, lower alkyl, cycloalkyl, phenyl, phenylated 

lower alkyl wherein the phenyl may be halogenated, phenoxylated lower alkyl, lower-alkoxy carbonyl-subsituted 
lower alkyl, carboxylated lower alkyl or lower alkenyl) or -NR⁷R⁸ (wherein R⁷ and R⁸ represent each independently 

hydrogen, lower alkyl, amino or cycloakyl, or R⁷ and R⁸ are combined together to form lower alkylene); and R⁴ and 
R⁵ represent each independently hydrogen or lower alkyl. 


</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OTSUKA PHARMA CO LTD
</APPLICANT-NAME>
<APPLICANT-NAME>
OTSUKA PHARMACEUTICAL FACTORY, INC.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
INOUE YASUHIDE
</INVENTOR-NAME>
<INVENTOR-NAME>
IWAMOTO TAKESHI
</INVENTOR-NAME>
<INVENTOR-NAME>
KANAYA JUN
</INVENTOR-NAME>
<INVENTOR-NAME>
KONDO MITSUYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
KUROGI YASUHISA
</INVENTOR-NAME>
<INVENTOR-NAME>
MIYATA KAZUYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
NABA CHIEKO
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA SHIZUO
</INVENTOR-NAME>
<INVENTOR-NAME>
SATO KEIGO
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUDA YOSHIHIKO
</INVENTOR-NAME>
<INVENTOR-NAME>
INOUE, YASUHIDE
</INVENTOR-NAME>
<INVENTOR-NAME>
IWAMOTO, TAKESHI
</INVENTOR-NAME>
<INVENTOR-NAME>
KANAYA, JUN
</INVENTOR-NAME>
<INVENTOR-NAME>
KONDO, MITSUYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
KUROGI, YASUHISA
</INVENTOR-NAME>
<INVENTOR-NAME>
MIYATA, KAZUYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
NABA, CHIEKO
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA, SHIZUO
</INVENTOR-NAME>
<INVENTOR-NAME>
SATO, KEIGO
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUDA, YOSHIHIKO
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
The present invention relates to novel phosphonic
diester derivatives.The phosphonic diester derivatives of the invention
are novel compounds not heretofore described in the
literature. Compounds having a similar pattern of
substituents than the compounds of the present invention, but
which are based on a quinoline heterocyclic system are
disclosed in JP-A-5 43589.The object of the invention is to provide compounds
of value as medicines as will be described hereinafter.The present invention provides a phosphonic diester
derivative of the following general formula (1):

wherein A represents an oxygen atom or a sulfur atom; R1,
R2, R9 and R10 are the same or different and they each
represent a hydrogen atom, a lower alkoxy group, a nitro
group, a lower alkyl group, a halogen-substituted lower
alkyl group or a halogen atom; R3 represents a phenyl
group, -B-R6 (wherein B represents an oxygen atom or a
sulfur atom and R6 represents a hydrogen atom, a lower
alkyl group, a cycloalkyl group, a phenyl group, a 
phenyl(lower)alkyl group optionally having a halogen atom
as a substituent on the phenyl ring, a phenoxy(lower)alkyl
group, a lower alkoxycarbonyl(lower)alkyl group, a
carboxy(lower)alkyl group or a lower alkenyl group) or
-NR7R8 (wherein R7 and R8 are the same or different and
they each represent a hydrogen atom, a lower alkyl group,
an amino group or a cycloalkyl group or combinedly
represent a lower alkylene group); and R4 and R5 are the
same or different and they each represent a hydrogen atom
or a lower alkyl group.Each of the groups relevant to the above general
formula (1) includes the following exemplary species.The lower alkyl group includes straight- or branched-chain
lower alkyl groups such as methyl, ethyl, propyl,
isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl and
so on.The cycloalkyl group includes cyclopropyl,
cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,
cyclooctyl and so on.The lower alkoxy group includes methoxy, ethoxy,
propoxy, butoxy, pentyloxy, hexyloxy and so on.The phenyl(lower)alkyl group optionally having a
halogen atom as a substituent on the phenyl ring includes
benzyl, α-phenetyl, β-phenetyl, 3-phenylpropyl, 4-phenylbutyl,
5-phenylpentyl, 6-phenylhexyl, 2-bromobenzyl, 
2-fluorobenzyl, 2-chlorobenzyl, 2-iodobenzyl, 3-bromobenzyl,
3-fluorobenzyl, 3-chlorobenzyl, 3-iodobenzyl,
4-bromobenzyl, 4-fluorobenzyl, 4-chlorobenzyl, 4-iodobenzyl,
4-bromo-3-fluorobenzyl, 4-bromo-2-fluorobenzyl,
3-bromo-4-fluorobenzyl, 2-bromo-4-fluorobenzyl,
4-bromo-3-chlorobenzyl,
</DESCRIPTION>
<CLAIMS>
A phosphonic diester derivative of the formula:


wherein A represents an oxygen atom or a sulfur atom; R
1
,
R
2
, R
9
 and R
10
 are the same or different and they each
represent a hydrogen atom, a lower alkoxy group, a nitro

group, a lower alkyl group, a halogen-substituted lower
alkyl group or a halogen atom; R
3
 represents a phenyl
group or -B-R
6
 (wherein B represents an oxygen atom or a
sulfur atom and R
6
 represents a hydrogen atom, a lower
alkyl group, a cycloalkyl group, a phenyl group, a

phenyl(lower)alkyl group optionally having a halogen atom
as a substituent on the phenyl ring, a phenoxy(lower)alkyl

group, a lower alkoxycarbonyl(lower)alkyl group, a
carboxy(lower)alkyl group or a lower alkenyl group) or

-NR
7
R
8
 (wherein R
7
 and R
8
 are the same or different and
they each represent a hydrogen atom, a lower alkyl group,

an amino group or a cycloalkyl group or combinedly
represent a lower alkylene group); and R
4
 and R
5
 are the
same or different and they each represent a hydrogen atom

or a lower alkyl group. 
A phosphonic diester derivative of the formula:


wherein A' represents an oxygen atom or a sulfur atom; R
1'

represents a hydrogen atom, a lower alkoxy group, a nitro
group or a halogen atom; R
2'
 represents a hydrogen atom, a
lower alkoxy group, a lower alkyl group, a halogen-substituted

lower alkyl group or a halogen atom; R
3'

represents a phenyl group, -O-R
6
 (wherein R
6
 represents a
hydrogen atom, a lower alkyl group, a cycloalkyl group, a

phenyl group, a phenyl(lower)alkyl group optionally having
a halogen atom as a substituent on the phenyl ring, a

phenoxy(lower)alkyl group, a lower alkoxycarbonyl(lower)-alkyl
group, a carboxy(lower)alkyl group or a lower

alkenyl group), -S-R
6'
 (wherein R
6'
 represents a hydrogen
atom, a lower alkyl group or a phenyl group) or -NR
7
R
8

(wherein R
7
 and R
8
 are the same or different and they each
represent a hydrogen atom, a lower alkyl group, an amino

group or a cycloalkyl group or combinedly represent a
lower alkylene group); R
4'
 represents a lower alkyl group;
R
5'
 represents a hydrogen atom or a lower alkyl group; R
9'

represents a hydrogen atom or a halogen atom; and R
10'

represents a hydrogen atom or a lower alkoxy group. 
The phosphonic diester derivative of Claim 2
which is represented by the formula 1' wherein R
1'
 and R
2'

each represent a lower alkoxy group; R
3'
 represents -O-R
6

wherein R
6
 represents a hydrogen atom, a lower alkyl
group, a cycloalkyl group, a phenyl group, a

phenyl(lower)alkyl group optionally having a halogen atom
as a substituent on the phenyl ring, a phenoxy(lower)alkyl

group, a lower alkoxycarbonyl(lower)alkyl group, a
carboxy(lower)alkyl group or a lower alkenyl group; A'

represents an oxygen group; and R
4'
 and R
5'
 each represent
a lower alkyl group.
The phosphonic diester derivative of Claim 2
which is represented by the formula 1' wherein R
9'
 and
R
10'
 each represent a hydrogen atom and R
3'
 represents a
hydroxy group, a lower alkoxy group, a phenyl(lower)alkoxy

group or a lower alkenyloxy group.
The phosphonic diester derivative of Claim 4
which is a compound selected from the class consisting of

(1) diethyl 4-(4-hydroxy-6,7-dimethoxyquinazolin-2-yl)benzylphosphonate,
(2) diisopropyl 4-(4-hydroxy-6,7-dimethoxyquinazolin-2-yl)benzylphosphonate,

(3) diethyl 4-(4,6,7-trimethoxyquinazolin-2-yl)benzylphosphonate,
(4)

diisopropyl 4-(4,6,7-trimethoxyquinazolin-2-yl)benzylphosphonate,
(5) diethyl 4-(4-benzyloxy-6,7-dimethoxyquinazolin-2-yl)benzylphosphonate

and (6) diethyl 
4-(4-allyloxy-6,7-dimethoxyquinazolin-2-yl)benzyl-phosphonate.
The phosphonic diester derivative of Claim 5
which is diethyl 4-(4,6,7-trimethoxyquinazolin-2-yl)benzylphosphonate

or diisopropyl 4-(4,6,7-trimethoxyquinazolin-2-yl)benzylphosphonate.
A pharmaceutical composition comprising the
phosphonic diester derivative claimed in any one of the

claims 1 through 6 as an active ingredient together with a
pharmacologically acceptable carrier.
A phosphonic diester derivative according to any of claims 1-6 for
use as a medicament.
Use of the phosphonic diester derivative claimed in any one of the
Claims 1-6 for the preparation of a composition for the treatment of

hyperlipidemic diseases, hypertension or diabetes
</CLAIMS>
</TEXT>
</DOC>
